Ads
related to: tecentriq- About TECENTRIQ®
Learn About TECENTRIQ® and Explore
Treatment Options On Patient Site.
- Treatment Process & Info
Find Important Safety Info & Read
About How TECENTRIQ® May Work.
- Caregiver Support Info
Caregivers Play An Important Role.
See Info & Tips For Caregivers.
- Receive A Care Guide
Sign Up To Receive Your Care Guide
& Useful Resources For TECENTRIQ®.
- FAQs
See Helpful Info & FAQs About
Treatment & Safety Information.
- Financial Assistance
Learn About Your Options That May
Help Pay For TECENTRIQ® Treatment.
- About TECENTRIQ®
Search results
Roche (RHHBY) Tecentriq SC Receives Positive CHMP Opinion
Zacks via Yahoo Finance· 6 months agoRoche RHHBY announced that the European Medicines Agency’s Committee for Medicinal Products for...
Roche's (RHHBY) Tecentriq Subcutaneous Gets Approval in the EU
Zacks via Yahoo Finance· 4 months agoRoche RHHBY announced that the European Commission has granted marketing authorization to...
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating...
Roche (RHHBY) Announces Data on Tecentriq Combo for HCC
Zacks via Yahoo Finance· 1 year agoRoche's (RHHBY) new data from the late-stage IMbrave050 study reveals that the combination of...
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
Benzinga via Yahoo Finance· 1 year agoGenentech, a unit of Roche Holdings AG (OTC: RHHBY), announced that the Phase 3 IMbrave050 study met...
Roche (RHHBY) Gets EU Nod for Lunsumio, Tecentriq Label Expansion
Zacks via Yahoo Finance· 2 years agoRoche (RHHBY) obtains EU approval for Lunsumio for the treatment of adult patients with relapsed or...
Pharma Stock Roundup: FDA Nod to GSK's MMR Jab & SNY's Dupixent Expanded Use
Zacks via Yahoo Finance· 2 years agoEuropean Commission approves Roche's (RHHBY) Tecentriq for a new indication. FDA gives the nod to...
Roche (RHHBY) Up on Upbeat Data From Combo Drug Cancer Study
Zacks via Yahoo Finance· 9 months agoRoche's (RHHBY) stock jumps 4.3% on Wednesday after the company inadvertently publishes encouraging...
Why Roche's Accidental Cancer Update Boosted Several Rivals By As Much As 22%
Investor's Business Daily· 9 months agoRoche accidentally published positive interim results from a lung cancer treatment study on...
Roche withdraws Tecentriq from U.S. bladder cancer indication
Reuters via Yahoo News· 1 year agoZURICH (Reuters) - Roche has voluntarily withdrawn the U.S. indication of Tecentriq for treating a...
Ads
related to: tecentriq
